![]() |
市場調查報告書
商品編碼
1880632
天然可吸收縫合線市場規模、佔有率、成長及全球產業分析:依類型、應用和地區劃分的洞察與預測(2024-2032)Natural Absorbable Sutures Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032 |
||||||
受外科手術量增加和對生物相容性傷口閉合材料需求成長的推動,全球天然可吸收縫合線市場持續穩定擴張。根據最新估計,2024年該市場規模將達到9.218億美元,主要得益於一般外科、婦科、心臟外科和骨科等領域的高使用率。人口老化和需要手術介入的慢性疾病盛行率不斷上升,預計到2025年該市場規模將增長至9.592億美元。到2032年,該市場預計將達到14.984億美元,預測期內複合年增長率將達到6.6%。
天然可吸收縫線通常由取自健康綿羊腸道的純化結締組織製成,廣泛用於內科手術。其生物降解性無需拆線,使其成為深部和難以觸及的手術部位的理想選擇。其良好的生物相容性和較低的組織反應使其在內科傷口管理中越來越優於不可吸收縫合線。
市場推動因素
人口老化加劇和手術量增加
全球老年人口的成長顯著推動了市場成長,尤其是在老年人群中,心臟外科、骨科和一般外科手術更為常見。在這些情況下,天然可吸收縫線對於術後傷口閉合至關重要。例如,根據澳洲健康與福利研究所的報告,2021年至2022年間共進行了12,700例冠狀動脈繞道手術(CABG)。同樣,人們對整形手術的需求也不斷增長。據國際美容整形外科學會稱,2023年全球將記錄超過352,000例男性女乳症手術,這將進一步推動縫線的使用。
市場限制因子
常用的傷口縫合替代方案
手術縫合器、組織黏合劑和合成可吸收縫線的普及正在逐漸限制天然縫線的使用。由聚乙醇酸(PGA)和聚乳酸(PLA)製成的合成產品具有更高的耐用性和可預測的吸收率。據Unicer Lifecare(2024)稱,皮膚縫合器可顯著縮短手術時間,並且是緊急傷口縫合的首選,這對天然可吸收縫合線的需求構成了挑戰。
市場機會
新興經濟體醫療基礎設施的擴張
發展中國家的醫療基礎設施正在顯著擴張,手術量也不斷增加。世界各國政府都在大力投資新建醫院、專科診所和先進的外科部門。新南威爾斯州投資7.233億澳元興建的特威德谷醫院(Tweed Valley Hospital)於2024年5月開業,就是一個醫療設施擴容支持市場成長的例證。
市場挑戰
天然縫合線的併發症
由於羊腸線縫合線可能引起發炎反應並增加感染風險,外科醫生正在轉向合成縫合線。諸如抗拉強度差異、潛在的過敏反應以及易感染等問題限制了合成縫合線的廣泛應用,尤其是在擁有嚴格感染控制規程的先進醫療機構中。
嚴格的監理審批要求
製造商必須遵守美國FDA和歐洲藥品管理局(EMA)等機構的嚴格規定。廣泛的臨床驗證和嚴格的品質文件會延長研發時間並增加成本,這對尋求推出新型天然縫線產品的中小型企業構成挑戰。
市場趨勢
鉻製Katgut縫合線的應用日益廣泛
鉻製Katgut縫合線因其更高的抗拉強度和更低的感染風險(透過鉻鹽溶液處理實現)而得到越來越廣泛的應用。其低成本和可生物降解性使其成為各種外科手術的首選。
微創手術中應用日益廣泛
由於天然可吸收縫線具有吸收順暢、生物相容性好以及適用於內部組織縫合等優點,進行腹腔鏡手術和婦科手術的外科醫生越來越多地選擇使用天然可吸收縫線。
北美 - 市場領導者(2024 年:3.334 億美元)
北美在 2024 年以 36.16% 的市佔率領先,這主要得益於其先進的醫療基礎設施和高手術量。在 FIME 2025 等醫療展會上,Dolphin Satures 展示了其天然可吸收縫線,進一步提高了產品知名度,並促進了該地區的採用。
歐洲
歐洲佔了較大的市場佔有率,這主要歸功於其骨科、心臟和普通外科手術量巨大。預計2022年英格蘭將記錄超過42,000例骨科手術,顯示該地區需求強勁。
亞太地區
由於醫療旅遊、手術量增加以及印度、中國和東南亞醫院基礎設施的擴建,亞太地區預計將以最高的複合年增長率增長。
拉丁美洲、中東和非洲
成長保持穩定,這得益於手術量增加以及當地醫療機構擴大採用低成本天然縫合線。
The global natural absorbable sutures market continues to expand steadily, fueled by rising surgical volumes and increasing demand for biocompatible wound closure materials. According to the latest estimates, the market was valued at USD 921.8 million in 2024, supported by strong usage in general surgery, gynecology, cardiology, and orthopedics. The value is projected to rise to USD 959.2 million in 2025, driven by a growing geriatric population and increasing prevalence of chronic diseases requiring surgical intervention. By 2032, the market is expected to reach USD 1,498.4 million, reflecting a healthy CAGR of 6.6% during the forecast period.
Natural absorbable sutures, typically made from purified connective tissue obtained from healthy sheep intestines, are widely used for internal surgical procedures. Their ability to biodegrade within the body eliminates the need for suture removal, making them ideal for deep and difficult-to-access surgical sites. Higher biocompatibility and reduced tissue reaction further enhance their preference over non-absorbable alternatives in internal wound management.
Market Drivers
Growing Geriatric Population & Rising Surgical Procedures
The global increase in the elderly population is significantly boosting market growth, as older individuals undergo a higher percentage of cardiac surgeries, orthopedic procedures, and general surgeries. Natural absorbable sutures are crucial for postoperative wound closure in these cases. For example, the Australian Institute of Health and Welfare reported 12,700 coronary artery bypass graft (CABG) procedures performed between 2021 and 2022. Similarly, the demand for aesthetic surgeries is growing, with the International Society of Aesthetic Plastic Surgery recording over 352,000 gynecomastia procedures globally in 2023, further driving suture usage.
Market Restraints
Rising Use of Alternative Wound Closure Methods
The adoption of surgical staplers, tissue adhesives, and synthetic absorbable sutures is increasingly limiting the uptake of natural sutures. Synthetic options made from PGA and PLA offer improved durability and predictable absorption rates. According to Unisur Lifecare (2024), skin staplers significantly reduce operating time and are preferred in emergency wound closures, challenging the demand for natural absorbable sutures.
Market Opportunities
Expanding Healthcare Infrastructure in Emerging Economies
Developing nations are witnessing substantial medical infrastructure expansion and rising surgical volumes. Governments are investing heavily in new hospitals, specialty clinics, and advanced surgical departments. The USD 723.3 million investment by New South Wales into the Tweed Valley Hospital, opened in May 2024, is an example of increasing institutional capacities that support market growth.
Market Challenges
Complications Associated with Natural Sutures
Catgut-based sutures may trigger inflammatory reactions and increase infection risk, leading surgeons to shift toward synthetic options. Variations in tensile strength, potential hypersensitivity, and higher infection susceptibility limit adoption, particularly in advanced healthcare settings with stringent infection-control protocols.
Stringent Regulatory Approval Requirements
Manufacturers must comply with rigorous regulations from authorities such as the U.S. FDA and EMA. Extensive clinical validation and strict quality documentation extend development timelines and increase costs, creating challenges for smaller companies aiming to launch new natural suture products.
Market Trends
Growing Adoption of Chromic Catgut Sutures
Chromic catgut sutures are increasingly used due to their improved tensile strength and reduced infection risk, achieved through the treatment of sutures in chromic salt solutions. Their low cost and biodegradability make them a preferred option in multiple surgical procedures.
Rising Use in Minimally Invasive Surgeries
Surgeons performing laparoscopic and gynecological procedures are increasingly opting for natural absorbable sutures due to their smooth absorption profile, biocompatibility, and suitability for internal tissue closures.
North America - Market Leader (USD 333.4 Million in 2024)
North America dominated the market in 2024 with 36.16% share, supported by advanced healthcare infrastructure and high surgical volumes. Medical events such as FIME 2025, where Dolphin Sutures showcased its natural dissolvable sutures, further enhance product visibility and regional adoption.
Europe
Europe holds a significant share driven by a high burden of orthopedic, cardiac, and general surgeries. More than 42,000 orthopedic operations were recorded in England in 2022, demonstrating strong regional demand.
Asia Pacific
Asia Pacific is projected to grow at the highest CAGR due to medical tourism, rising surgical volumes, and expanding hospital infrastructure across India, China, and Southeast Asia.
Latin America & Middle East/Africa
Growth remains steady, supported by increasing surgical procedures and higher adoption of low-cost natural sutures in local healthcare facilities.
Conclusion
With global value increasing from USD 921.8 million in 2024 to USD 1,498.4 million by 2032, the natural absorbable sutures market is poised for steady growth. Rising surgical demand, aging populations, and improvements in medical infrastructure will continue to drive expansion, despite challenges posed by alternative wound closure methods and regulatory complexities.
Segmentation By Product, Material, Application, End-user, and Region
By Product * Monofilament
By Material * Catgut Chromic Sutures
By Application * Gynecology
By End-user * Hospitals & ASCs
By Region * North America (by Product, by Material, by Application, by End-user, and by Country/Sub-Region)